Executive Profile*

Nancy June Hutson Ph.D.

AgeTotal Calculated CompensationThis person is connected to 56 board members in 7 different organizations across 7 different industries.

See Board Relationships
67$165,022

Background*

Dr. Nancy June Hutson, Ph.D., serves as the Chair of the Groton New London Laboratories Leadership Team and the Exploratory Development Strategy Team. Dr. Hutson has been an Independent Director of Endo International plc since February 28, 2014. She has been a Director of BioCryst Pharmaceuticals, Inc. since January 20, 2012 and Inspire Pharmaceuticals, Inc. since October 27, 2006. She has been a Director of Endo Pharmaceuticals Solutions Inc. since March 30, 2009. She ...

Read Full Background

Corporate Headquarters*

65 Hayden Avenue
Lexington, Massachusetts 02421

United States

Phone: 781-860-8660
Fax: --

Board Members Memberships*

Trustee
Director
2006-Present
Director
2009-Present
Director
2012-Present
Director
2014-Present
Independent Director

Education*

PhD
Vanderbilt University
Post-Doctoral Training
Vanderbilt University
BA
Illinois Wesleyan University
Post-Doctoral Training
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$47,833
Total Calculated Compensation$165,022
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Sijmen de Vries M.D., MBAChairman of Management Board and Chief Executive Officer
Pharming Group N.V.
€626.0K
Andrew Philip Witty Chief Executive Officer and Executive Director
GlaxoSmithKline plc
3.3M GBP
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$4.3M
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
¥140.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.